Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan L Ho

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Cancer Research|February 8, 2023
Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck CancerSankar Jagadeeshan, Manu Prasad, Mai Badarni, et al.
JAMA Network Open|November 11, 2022
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation TherapyIrini Youssef, Jennifer Yoon, Nader Mohamed, et al.
European Radiology|April 20, 2026
Staging of non-metastatic nasopharyngeal carcinoma with PET/CTCaineng Cao, Teeradon Treechairusame, Yingzhi Wu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 7, 2012
Dermatofibrosarcoma protuberansStanley J Miller, Murad Alam, James S Andersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2026
Genomic enrichment and functional impact of TP53 and CYLD alterations in recurrent and metastatic HPV-associated head and neck cancerManu Prasad, Alex T Cheng, Marcel Mayer, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2025
Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study)Linda Chen, Marc Cohen, Vaios Hatzglou, et al.
JCO Precision Oncology|October 9, 2025
Phase II Study of Vismodegib in Patients With <i>SMO-</i> or <i>PTCH1</i>-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol TAnne S Tsao, Zihe Song, Alan L Ho, et al.
JAMA Oncology|July 22, 2016
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing PlatformLuc G T Morris, Raghu Chandramohan, Lyndsay West, et al.
Nature Medicine|August 24, 2023
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trialJoris L Vos, Bharat Burman, Swati Jain, et al.
The Journal of Clinical Investigation|September 5, 2019
Genetic hallmarks of recurrent/metastatic adenoid cystic carcinomaAllen S Ho, Angelica Ochoa, Gowtham Jayakumaran, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Cancer Research|February 8, 2023
Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck CancerSankar Jagadeeshan, Manu Prasad, Mai Badarni, et al.
JAMA Network Open|November 11, 2022
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation TherapyIrini Youssef, Jennifer Yoon, Nader Mohamed, et al.
European Radiology|April 20, 2026
Staging of non-metastatic nasopharyngeal carcinoma with PET/CTCaineng Cao, Teeradon Treechairusame, Yingzhi Wu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 7, 2012
Dermatofibrosarcoma protuberansStanley J Miller, Murad Alam, James S Andersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2026
Genomic enrichment and functional impact of TP53 and CYLD alterations in recurrent and metastatic HPV-associated head and neck cancerManu Prasad, Alex T Cheng, Marcel Mayer, et al.
International Journal of Radiation Oncology, Biology, Physics|October 3, 2025
Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study)Linda Chen, Marc Cohen, Vaios Hatzglou, et al.
JCO Precision Oncology|October 9, 2025
Phase II Study of Vismodegib in Patients With <i>SMO-</i> or <i>PTCH1</i>-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol TAnne S Tsao, Zihe Song, Alan L Ho, et al.
JAMA Oncology|July 22, 2016
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing PlatformLuc G T Morris, Raghu Chandramohan, Lyndsay West, et al.
Nature Medicine|August 24, 2023
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trialJoris L Vos, Bharat Burman, Swati Jain, et al.
The Journal of Clinical Investigation|September 5, 2019
Genetic hallmarks of recurrent/metastatic adenoid cystic carcinomaAllen S Ho, Angelica Ochoa, Gowtham Jayakumaran, et al.
Pageof 12